NovaBridge Biosciences (NBP): who owns it and who trades it
As of Nov 16, 2026, NBP insiders reported 7 open-market sales worth $154K and 1 purchase worth $577K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Sean Wuxiong Cao (Director), with $122K. 2 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling NovaBridge Biosciences
From the latest filingsOverall: more selling than buying. Insiders mostly sold. Funds and famous investors were close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns NBP
49 funds and institutions reported NBP shares worth $48.1M at the end of Q2 2026, about 9% of the company. The largest holder is Hhlr Advisors, Ltd. with 2.3%.
Funds and institutions (13F) 9%Everyone else 91%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Hhlr Advisors, Ltd. | 5.98M | 2.25% | $11.7M | No change |
| Morgan Stanley | 3.65M | 1.38% | $7.1M | -5% |
| AIHC Capital Management Ltd | 2.88M | 1.08% | $5.6M | +27% |
| Siren, L.L.C. | 2.00M | 0.76% | $3.9M | -33% |
| Marshall Wace, LLP | 1.23M | 0.46% | $2.4M | New |
| Candriam S.C.A. | 1.13M | 0.43% | $2.2M | No change |
| Adage Capital Partners Gp, L.l.c. | 1.00M | 0.38% | $1.9M | No change |
| Two Sigma Investments, LP | 851,348 | 0.32% | $1.7M | New |
| Renaissance Technologies LLC | 758,226 | 0.29% | $1.5M | +178% |
| BlackRock, Inc. | 686,208 | 0.26% | $1.3M | +9% |
| Citadel Advisors LLC | 622,831 | 0.23% | $1.2M | +274% |
| E Fund Management Co., Ltd. | 589,020 | 0.22% | $1.1M | New |
| Exome Asset Management LLC | 576,960 | 0.22% | $1.1M | No change |
| State Street Corp | 360,376 | 0.14% | $703K | -3% |
| Woodline Partners LP | 350,000 | 0.13% | $682K | -50% |
| Fiera Capital Corp | 315,681 | 0.12% | $616K | No change |
| UBS Group AG | 301,780 | 0.11% | $588K | +375% |
| Barclays PLC | 279,019 | 0.11% | $544K | -7% |
| Taikang Asset Management (Hong Kong) Co Ltd | 170,931 | 0.06% | $333K | No change |
| Goldman Sachs Group Inc | 161,321 | 0.06% | $315K | +43% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, NBP insiders reported $577K of open-market purchases and $154K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Phillip Andrew Dennis | Chief Medical Officer | Sale | 8,209 | $0.71 | $5.8K | Form 4 |
| Sep 9, 2026 | Sean Wuxiong Cao | Chief Bus. Development O | Sale | 107,978 | $0.74 | $79.9K | Form 4 |
| Aug 31, 2026 | Cong Claire Xu | Vice president | Sale | 3,282 | $0.79 | $2.6K | Form 4 |
| Jul 6, 2026 | Cong Claire Xu | Vice president | Sale | 4,485 | $0.89 | $4K | Form 4 |
| Jun 18, 2026 | Phillip Andrew Dennis | Chief Medical Officer | Sale | 8,494 | $0.66 | $5.6K | Form 4 |
| Jun 1, 2026 | Cong Claire Xu | Vice president | Sale | 3,494 | $3.94 | $13.8K | Form 4 |
| May 14, 2026 | Sean Wuxiong Cao | Director | Sale | 21,399 | $1.99 | $42.6K | Form 4 |
| Apr 24, 2026 | Mark Arnold Hagler | See Remarks | Purchase | 230,000 | $2.51 | $577K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Mark Arnold Hagler | See Remarks | $577K | – | Apr 24, 2026 |
| Sean Wuxiong Cao | See Remarks, Director | – | $122K | Sep 9, 2026 |
| Cong Claire Xu | SVP, Clinical Development | – | $20.4K | Aug 31, 2026 |
| Phillip Andrew Dennis | Chief Medical Officer | – | $11.4K | Sep 18, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
NBP short interest
3.58M NBP shares are sold short. Over the last 12 reports the number of shares short went down 28%.
As of Oct 30, 2026, 3.58M NBP shares were sold short, down 3.3% from the report before. At the average daily volume of 519,491 shares, buying them all back would take about 6.9 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 3.58M | – | -3% | 519,491 | 6.9 |
| Oct 15, 2026 | 3.70M | – | +13% | 349,872 | 10.6 |
| Sep 30, 2026 | 3.28M | – | -12% | 931,895 | 3.5 |
| Sep 15, 2026 | 3.75M | – | +5% | 219,198 | 17.1 |
| Aug 31, 2026 | 3.58M | – | -22% | 293,280 | 12.2 |
| Aug 14, 2026 | 4.58M | – | +1% | 225,162 | 20.3 |
| Jul 31, 2026 | 4.52M | – | +4% | 259,475 | 17.4 |
| Jul 15, 2026 | 4.33M | 1.63% | +25% | 712,132 | 6.1 |
| Jun 30, 2026 | 3.47M | 1.31% | -17% | 846,887 | 4.1 |
| Jun 15, 2026 | 4.16M | 1.57% | +16% | 491,271 | 8.5 |
| May 29, 2026 | 3.58M | 1.35% | -27% | 800,719 | 4.5 |
| May 15, 2026 | 4.94M | 1.86% | +20% | 1.08M | 4.6 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
NovaBridge Biosciences financials
Famous investors that hold NBP
2 of the 50 well-known investors we track reported holding NBP in their latest 13F filing. The largest position is Ken Griffin's, worth $1.9M.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 1.38M | $1.9M | 0.0% | +122% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 485,191 | $662K | 0.0% | -36% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named NBP in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 5, 2026 | HHLR Advisors, Ltd. | 13D/A | 4.9% |
| Nov 5, 2026 | HHLR Advisors, Ltd. | 13D/A | 4.9% |
Questions about NovaBridge Biosciences (NBP) stock
Who owns the most NBP stock?
The largest reported owner of NovaBridge Biosciences (NBP) is Hhlr Advisors, Ltd., with 2.3% of the company. In total, 49 funds and institutions reported holding NBP at the end of Q2 2026, together about 9% of the shares. See the largest owners.
Are NBP insiders buying or selling?
In the last 12 months, NBP insiders reported 1 open-market purchase worth $577K and 7 sales worth $154K. The latest trade was on Sep 18, 2026. See every trade.
What is the short interest in NBP?
As of Oct 30, 2026, 3.58M NBP shares were sold short, down 3.3% from the report before. At the average daily volume of 519,491 shares, buying them all back would take about 6.9 trading days (days to cover). See the history.
Which famous investors hold NBP?
2 of the 50 well-known investors we track reported NBP in their latest 13F filing, including Ken Griffin, Jim Simons. The largest position is worth $1.9M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.